Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Biotechnol. 2002 Jan;20(1):36-42.

Full-speed mammalian genetics: in vivo target validation in the drug discovery process.

Author information

1
Lexicon Genetics Incorporated, 4000 Research Forest Drive, The Woodlands, TX 77381, USA.

Abstract

The completion of the Human Genome Project has signaled the beginning of the post-genome era, with a corresponding shift in focus from the sequencing and identification of genes to the exploration of gene function. A rate-limiting step in deriving value from this gene sequence information is determining the potential pharmaceutical applications of genes and their encoded proteins. This validation step is crucial for focusing efforts and resources on only the most promising targets. Strategies using reverse mouse genetics provide excellent methods for validating potential targets and therapeutic proteins in vivo in a mammalian model system.

PMID:
11742676
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center